Skip to main content

Hydroxyamphetamine Hydrobromide and Tropicamide Ophthalmic Solution Shortage

Last Updated: April 25, 2017
Status: Resolved

Reason for the Shortage
    • Akorn had Paremyd on shortage due to manufacturing delays.
    • No clinical trial data were found to support the use of Paremyd in the diagnosis of Horner Syndrome.
Available Products
    • Paremyd ophthalmic solution, Akorn, 1% hydroxyamphetamine hydrobromide and 0.25% tropicamide, 15 mL bottle, 1 count, NDC 17478-0704-12

Estimated Resupply Dates

    • Akorn has Paremyd ophthalmic solution available.


Updated April 25, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 13, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.